Search
Hengrui Medicine Receives Approval for Eltrombopag Ethanolamine Tablets Marketing Authorization from National Medical Products Administration
2025-08-18 /
Read about 0 minute
Author：小编
Hengrui Medicine is pleased to announce that it has received the "Notice of Acceptance" from the National Medical Products Administration, marking the approval of its application for the marketing authorization of Eltrombopag Ethanolamine Tablets. This drug is specifically indicated for the treatment of chemotherapy-induced thrombocytopenia in adult patients undergoing anti-tumor therapy. Prior to this approval, the drug had already been authorized for two other indications.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
